COLL vs GD · P/E 17, rev $181.9M vs P/E 22, rev $52.55B
Collegium Pharmaceutical Inc (COLL) versus General Dynamics Corporation (GD) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
General Dynamics Corporation (GD) is a aerospace & defense company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported GD revenue for 2025-12-31 was $52.55B. Net income was $4.21B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. GD currently screens at market cap $93.69B and trailing P/E 21.8.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. GD currently screens at market cap $93.69B and trailing P/E 21.8.
Not investment advice. Open the COLL and GD stock pages for the full models.
Not investment advice.